Understanding the BMI requirements for GLP-1 medications is the first step toward determining whether you may qualify for treatment with drugs like Wegovy, Ozempic, Mounjaro, or Zepbound. While BMI thresholds serve as the primary eligibility criteria, the full picture includes additional health factors, insurance considerations, and evolving clinical guidelines. This guide explains who qualifies for GLP-1 medications, how BMI is calculated, and what to do if you're close to the cutoff.
FDA-Approved BMI Criteria for GLP-1 Weight Management Medications
The FDA has established specific BMI thresholds for GLP-1 medications approved for chronic weight management:
Standard Eligibility
You may qualify for FDA-approved weight management GLP-1 medications if you meet either of these criteria:
- BMI of 30 or higher (classified as obesity) — regardless of other health conditions
- BMI of 27 or higher (classified as overweight) — with at least one weight-related health condition
What Qualifies as a Weight-Related Health Condition?
If your BMI is between 27 and 30, you need at least one of these conditions to meet FDA criteria:
- Type 2 diabetes or prediabetes
- Hypertension (high blood pressure)
- Dyslipidemia (high cholesterol or triglycerides)
- Obstructive sleep apnea
- Cardiovascular disease (heart disease, history of heart attack or stroke)
- Non-alcoholic fatty liver disease (NAFLD/MASH)
- Osteoarthritis related to excess weight
- Polycystic ovary syndrome (PCOS)
BMI Requirements by Medication
| Medication | FDA Approval | BMI Requirement |
|---|---|---|
| Wegovy (semaglutide 2.4 mg) | Weight management | ≥30, or ≥27 with comorbidity |
| Zepbound (tirzepatide) | Weight management | ≥30, or ≥27 with comorbidity |
| Saxenda (liraglutide 3.0 mg) | Weight management | ≥30, or ≥27 with comorbidity |
| Ozempic (semaglutide) | Type 2 diabetes | BMI not specified (diabetes diagnosis required) |
| Mounjaro (tirzepatide) | Type 2 diabetes | BMI not specified (diabetes diagnosis required) |
How to Calculate Your BMI
The BMI Formula
BMI = weight (lbs) ÷ height (inches)² × 703
Or simply: BMI = weight (kg) ÷ height (m)²
BMI Reference Chart
| Height | BMI 25 (Overweight) | BMI 27 (Qualify w/ condition) | BMI 30 (Qualify alone) | BMI 35 | BMI 40 |
|---|---|---|---|---|---|
| 5'0" | 128 lbs | 138 lbs | 153 lbs | 179 lbs | 204 lbs |
| 5'2" | 136 lbs | 148 lbs | 164 lbs | 191 lbs | 218 lbs |
| 5'4" | 145 lbs | 157 lbs | 174 lbs | 204 lbs | 233 lbs |
| 5'6" | 155 lbs | 167 lbs | 186 lbs | 216 lbs | 247 lbs |
| 5'8" | 164 lbs | 177 lbs | 197 lbs | 230 lbs | 262 lbs |
| 5'10" | 174 lbs | 188 lbs | 209 lbs | 243 lbs | 278 lbs |
| 6'0" | 184 lbs | 199 lbs | 221 lbs | 258 lbs | 294 lbs |
| 6'2" | 194 lbs | 211 lbs | 234 lbs | 272 lbs | 311 lbs |
| 6'4" | 205 lbs | 222 lbs | 246 lbs | 287 lbs | 328 lbs |
BMI Categories
- Under 18.5: Underweight
- 18.5–24.9: Normal weight
- 25.0–29.9: Overweight
- 30.0–34.9: Class I obesity
- 35.0–39.9: Class II obesity
- 40.0+: Class III obesity (severe)
The Limitations of BMI
Take our quick eligibility quiz to find out if you may qualify.
While BMI is the standard measure used for GLP-1 eligibility, it's important to understand its limitations:
What BMI Doesn't Measure
- Body composition: BMI doesn't distinguish between muscle and fat. A muscular athlete may have a "high" BMI without excess body fat.
- Fat distribution: Where you carry fat matters. Visceral fat (around organs) poses more health risks than subcutaneous fat, but BMI doesn't differentiate.
- Ethnic variations: Research suggests BMI-related health risks may begin at lower thresholds for certain populations (notably South Asian, East Asian, and Hispanic populations).
- Individual health: Two people with the same BMI can have vastly different metabolic health profiles.
Evolving Clinical Perspectives
Medical organizations are increasingly recognizing the limitations of BMI as the sole measure of obesity-related health risk. Some clinicians now consider additional metrics:
- Waist circumference: Men ≥40 inches, women ≥35 inches suggests elevated risk
- Waist-to-hip ratio
- Body fat percentage
- Metabolic health markers (blood sugar, lipids, blood pressure, inflammatory markers)
However, BMI remains the primary regulatory and insurance criterion for GLP-1 medication eligibility.
Insurance Requirements Beyond BMI
Meeting the BMI threshold is just the beginning. Insurance companies often have additional requirements:
Common Prior Authorization Requirements
- Documented weight loss attempts: Many insurers require evidence of previous attempts (diet counseling, exercise programs, other medications)
- Duration of obesity: Some require documentation that your BMI has been elevated for a specific period
- Specialist involvement: May require evaluation by an endocrinologist or obesity medicine specialist
- Step therapy: May require trying less expensive medications first
Documentation Tips
To improve your chances of insurance approval:
- Ask your provider to document your BMI at every visit
- Keep records of all weight loss attempts (programs, diets, gym memberships)
- Have your provider document weight-related health conditions thoroughly
- Request that comorbidities are coded properly in your medical records
- Submit appeal letters if initially denied — many denials are overturned on appeal
Coverage Variations
Insurance coverage for GLP-1 weight management medications varies significantly:
- Commercial insurance: Increasingly covering Wegovy and Zepbound, often with prior authorization
- Medicare: As of 2025, Medicare began covering some anti-obesity medications under certain conditions; check current policy
- Medicaid: Coverage varies by state
- Self-funded employer plans: May have different criteria than fully insured plans
- Military/VA: Coverage available for qualifying members
What If You're Close to the BMI Cutoff?
If your BMI is close to 27 or 30, you have several options:
Document Comorbidities
If your BMI is between 27 and 30, having a documented weight-related condition opens the door to FDA-approved weight management medications. Work with your provider to ensure all relevant conditions are properly diagnosed and documented.
Consider Off-Label Options
Some healthcare providers prescribe GLP-1 medications off-label for patients who don't quite meet BMI cutoffs but have other clinical justifications. This is a provider-by-provider decision and typically won't be covered by insurance.
Telehealth Platforms
Some telehealth providers may evaluate eligibility using a broader set of criteria beyond strict BMI cutoffs . They may consider:
- Body composition analysis
- Metabolic health markers
- Personal and family health history
- Previous weight loss struggles
Discuss Emerging Guidelines
Some medical organizations and providers are moving toward a more holistic approach to obesity assessment that considers metabolic health alongside BMI. Your provider may be willing to consider these evolving perspectives.
BMI Requirements for Special Populations
Take our quick eligibility quiz to find out if you may qualify.
Adolescents (Ages 12+)
Some GLP-1 medications are approved for adolescents:
- Wegovy: Approved for ages 12+ with initial BMI at or above the 95th percentile for age and sex
- Saxenda: Approved for ages 12+ with body weight above 132 lbs (60 kg) and initial BMI at or above the 95th percentile
Ethnic Considerations
Research supports lower BMI cutoffs for certain populations:
- Asian populations: The World Health Organization recommends overweight classification beginning at BMI ≥23 and obesity at BMI ≥27.5 for Asian populations
- South Asian populations: Elevated cardiometabolic risk may begin at even lower BMIs
- Some clinicians apply these adjusted thresholds when evaluating eligibility, though insurance criteria typically still use standard cutoffs
Older Adults
For adults over 65:
- BMI criteria remain the same
- Additional considerations include fall risk, muscle mass preservation, and nutritional status
- The risk-benefit calculation may differ from younger patients
- Provider evaluation of overall health status is particularly important
The GLP-1 Eligibility Process: Step by Step
Step 1: Calculate Your BMI
Use the formula or reference chart above, or use an online BMI calculator.
Step 2: Identify Weight-Related Conditions
Review the list of qualifying comorbidities and identify any that apply to you.
Step 3: Schedule a Medical Evaluation
Whether through your primary care provider, an obesity medicine specialist, or a telehealth platform , schedule an evaluation to discuss GLP-1 medications.
Step 4: Gather Documentation
Bring records of previous weight loss attempts, relevant lab work, and a list of current medications and health conditions.
Step 5: Discuss Options with Your Provider
Your provider will evaluate your eligibility, recommend specific medications, and help navigate insurance requirements.
Step 6: Submit for Insurance Approval (if applicable)
Your provider's office will typically handle prior authorization. Be prepared for potential back-and-forth with your insurer.
Frequently Asked Questions
Can I get GLP-1 medications with a BMI under 27?
FDA-approved weight management GLP-1 medications require a BMI of at least 27 (with a comorbidity) or 30. Some providers may prescribe off-label for patients below these thresholds in specific clinical situations, but this is uncommon and generally not covered by insurance. If your BMI is below 27, discuss alternative weight management strategies with your provider.
Does my BMI need to stay above the threshold to continue GLP-1 treatment?
Once you've been prescribed a GLP-1 medication and your BMI drops below the initial qualifying threshold due to weight loss, you can typically continue treatment. The eligibility criteria apply to initial prescribing. Continuing treatment after successful weight loss is considered appropriate medical practice since stopping often leads to weight regain.
How accurate is BMI as a measure of health?
BMI is a useful screening tool but has limitations. It doesn't account for body composition, fat distribution, or individual metabolic health. A person with a high BMI due to muscle mass may be metabolically healthy, while someone with a "normal" BMI may have excess visceral fat and metabolic dysfunction. That said, BMI remains the standard regulatory criterion, and population-level data consistently shows health risks increasing with higher BMI.
Can I use my highest recorded BMI to qualify?
Generally, providers use your current BMI at the time of prescribing. However, if your weight fluctuates and your BMI was recently above the threshold, your provider may consider your weight history when evaluating eligibility. Documenting your weight trajectory over time with your provider is helpful.
Are BMI requirements different for diabetes medications like Ozempic?
Yes. Ozempic and Mounjaro are FDA-approved for type 2 diabetes and don't have specific BMI requirements — you need a diabetes diagnosis instead. However, if you're seeking these medications specifically for weight loss (off-label), providers will typically still consider your BMI as part of the clinical evaluation. Insurance coverage for these diabetes medications requires a diabetes diagnosis.
Taking the Next Step
Take our quick eligibility quiz to find out if you may qualify.
Understanding BMI requirements for GLP-1 medications is the first step toward exploring your treatment options. If you think you may qualify — or even if you're unsure — the best approach is to connect with a healthcare provider who can evaluate your individual situation and guide you through the eligibility and insurance process.
Ready to explore your options? Take our free eligibility quiz →
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting any medication.
Take our 2-minute eligibility quiz and connect with a licensed telehealth provider.
⚕️ Medical Disclaimer
This article is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan. Individual results vary. GLP-1 medications are prescription drugs and should only be used under medical supervision.